sales@angenesci.com
Login | Register
logo
Structures Search
Home Aminos 2-(Benzoylamino)benzoic acid

2-(Benzoylamino)benzoic acid

CAS No.:
579-93-1
Catalog Number:
AG00EFVP
Molecular Formula:
C14H11NO3
Molecular Weight:
241.2420
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
98%
In Stock USA
United States
$57
- +
5g
98%
In Stock USA
United States
$175
- +
10g
98%
In Stock USA
United States
$282
- +
25g
98%
In Stock USA
United States
$563
- +
Product Description
Catalog Number:
AG00EFVP
Chemical Name:
2-(Benzoylamino)benzoic acid
CAS Number:
579-93-1
Molecular Formula:
C14H11NO3
Molecular Weight:
241.2420
MDL Number:
MFCD00444173
IUPAC Name:
2-benzamidobenzoic acid
InChI:
InChI=1S/C14H11NO3/c16-13(10-6-2-1-3-7-10)15-12-9-5-4-8-11(12)14(17)18/h1-9H,(H,15,16)(H,17,18)
InChI Key:
WXVLIIDDWFGYCV-UHFFFAOYSA-N
SMILES:
O=C(c1ccccc1)Nc1ccccc1C(=O)O
UNII:
6085493379
NSC Number:
3866
FEMA Number:
4078
Properties
Complexity:
310  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
241.074g/mol
Formal Charge:
0
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
241.246g/mol
Monoisotopic Mass:
241.074g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
66.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.5  
Literature
Title Journal
N-Benzoyl anthranilic acid derivatives as selective inhibitors of aldo-keto reductase AKR1C3. Bioorganic & medicinal chemistry letters 20120915
Anthranilic acid-based inhibitors of phosphodiesterase: design, synthesis, and bioactive evaluation. Organic & biomolecular chemistry 20111021
Inhibitors of the salicylate synthase (MbtI) from Mycobacterium tuberculosis discovered by high-throughput screening. ChemMedChem 20101203
DSM-RX78, a new phosphodiesterase inhibitor, suppresses superoxide anion production in activated human neutrophils and attenuates hemorrhagic shock-induced lung injury in rats. Biochemical pharmacology 20091015
Disubstituted 4(3H) quinazolones: a novel class of antitumor agents. Chemical biology & drug design 20090901
In silico screening for PTPN22 inhibitors: active hits from an inactive phosphatase conformation. ChemMedChem 20090301
Synthesis and anti-platelet evaluation of 2-benzoylaminobenzoate analogs. Bioorganic & medicinal chemistry 20080515
QSAR studies on benzoylaminobenzoic acid derivatives as inhibitors of beta-ketoacyl-acyl carrier protein synthase III. European journal of medicinal chemistry 20080501
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo-keto reductase AKR1C3: new lead compounds for the development of anticancer agents. Bioorganic & medicinal chemistry letters 20051201
Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents. Journal of medicinal chemistry 20050310
NMR-driven discovery of benzoylanthranilic acid inhibitors of far upstream element binding protein binding to the human oncogene c-myc promoter. Journal of medicinal chemistry 20040923
Properties